PL2317852T3 - Preparaty farmaceutyczne zawierające ligandy receptora dopaminy - Google Patents
Preparaty farmaceutyczne zawierające ligandy receptora dopaminyInfo
- Publication number
- PL2317852T3 PL2317852T3 PL09798745T PL09798745T PL2317852T3 PL 2317852 T3 PL2317852 T3 PL 2317852T3 PL 09798745 T PL09798745 T PL 09798745T PL 09798745 T PL09798745 T PL 09798745T PL 2317852 T3 PL2317852 T3 PL 2317852T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical formulations
- formulations containing
- receptor ligands
- dopamine receptor
- containing dopamine
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N25/00—Circuitry of solid-state image sensors [SSIS]; Control thereof
- H04N25/70—SSIS architectures; Circuits associated therewith
- H04N25/71—Charge-coupled device [CCD] sensors; Charge-transfer registers specially adapted for CCD sensors
- H04N25/75—Circuitry for providing, modifying or processing image signals from the pixel array
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N25/00—Circuitry of solid-state image sensors [SSIS]; Control thereof
- H04N25/70—SSIS architectures; Circuits associated therewith
- H04N25/76—Addressed sensors, e.g. MOS or CMOS sensors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Multimedia (AREA)
- Hospice & Palliative Care (AREA)
- Signal Processing (AREA)
- Anesthesiology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8105208P | 2008-07-16 | 2008-07-16 | |
EP09798745.7A EP2317852B1 (en) | 2008-07-16 | 2009-07-16 | Pharmaceutical formulations containing dopamine receptor ligands |
PCT/US2009/050835 WO2010009309A1 (en) | 2008-07-16 | 2009-07-16 | Pharmaceutical formulations containing dopamine receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2317852T3 true PL2317852T3 (pl) | 2015-05-29 |
Family
ID=41530841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09798745T PL2317852T3 (pl) | 2008-07-16 | 2009-07-16 | Preparaty farmaceutyczne zawierające ligandy receptora dopaminy |
Country Status (33)
Country | Link |
---|---|
US (6) | US9056845B2 (pl) |
EP (1) | EP2317852B1 (pl) |
JP (1) | JP5774988B2 (pl) |
KR (1) | KR101612146B1 (pl) |
CN (2) | CN102118970A (pl) |
AP (1) | AP2975A (pl) |
AU (1) | AU2009270823B2 (pl) |
BR (1) | BRPI0916241A2 (pl) |
CA (1) | CA2730287C (pl) |
CL (1) | CL2011000091A1 (pl) |
CO (1) | CO6351689A2 (pl) |
CY (1) | CY1115994T1 (pl) |
DK (1) | DK2317852T3 (pl) |
EA (1) | EA025636B1 (pl) |
EC (1) | ECSP11010834A (pl) |
ES (1) | ES2532636T3 (pl) |
GE (1) | GEP20146052B (pl) |
HR (1) | HRP20150196T1 (pl) |
IL (1) | IL210615A (pl) |
MA (1) | MA32568B1 (pl) |
MX (1) | MX2011000622A (pl) |
MY (1) | MY156288A (pl) |
NI (1) | NI201100016A (pl) |
NZ (1) | NZ590852A (pl) |
PL (1) | PL2317852T3 (pl) |
PT (1) | PT2317852E (pl) |
RS (1) | RS53866B1 (pl) |
SG (1) | SG192507A1 (pl) |
SI (1) | SI2317852T1 (pl) |
SM (1) | SMT201500063B (pl) |
UA (1) | UA104869C2 (pl) |
WO (1) | WO2010009309A1 (pl) |
ZA (1) | ZA201101134B (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0700353A2 (en) | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
EP2251011B1 (en) * | 2008-02-21 | 2012-04-04 | Richter Gedeon Nyrt. | Solid preparation for oral administration |
PL2317852T3 (pl) * | 2008-07-16 | 2015-05-29 | Richter Gedeon Nyrt | Preparaty farmaceutyczne zawierające ligandy receptora dopaminy |
HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
US8717044B2 (en) | 2010-04-23 | 2014-05-06 | Apple Inc. | Charging systems with direct charging port support and extended capabilities |
WO2014031162A1 (en) | 2012-08-20 | 2014-02-27 | Forest Laboratories Holdings Limited | Crystalline form of carbamoyl-cyclohexane derivatives |
EP2990029A1 (en) * | 2014-08-29 | 2016-03-02 | Sandoz Ag | Pharmaceutical compositions comprising Canagliflozin |
CN106560179B (zh) * | 2015-09-30 | 2020-02-21 | 石药集团中奇制药技术(石家庄)有限公司 | 盐酸卡利拉嗪药物组合物及其制备方法 |
EP3231418A1 (en) * | 2016-04-14 | 2017-10-18 | Richter Gedeon Nyrt. | Granule formulation for oral administration |
US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
CN107970217A (zh) * | 2016-10-25 | 2018-05-01 | 浙江京新药业股份有限公司 | 卡利拉嗪口腔崩解片及其制备方法 |
HUP1700253A1 (hu) | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
CN109589315A (zh) * | 2017-10-01 | 2019-04-09 | 北京万全德众医药生物技术有限公司 | 卡利拉嗪-亲水性材料共混物固体制剂的制备方法 |
US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
HU231500B1 (hu) | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
HUP2200312A1 (hu) * | 2022-08-05 | 2024-02-28 | Richter Gedeon Nyrt | Kariprazin tartalmú szájban diszpergálódó tabletta |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666911A (en) | 1981-07-14 | 1987-05-19 | Taiho Pharmaceutical Company Limited | Allophanoylpiperazine compound and analgesic composition containing same as active ingredient |
DE3540150A1 (de) | 1985-11-13 | 1987-05-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
US4880797A (en) | 1986-03-20 | 1989-11-14 | Banyu Pharmaceutical Co., Ltd. | Cephalosporin derivatives and antibacterial agents |
JPH01199977A (ja) | 1987-11-16 | 1989-08-11 | Mochida Pharmaceut Co Ltd | セファロスポリン誘導体の結晶、その製造法およびそれらを有効成分とする医薬組成物 |
GB8802622D0 (en) | 1988-02-05 | 1988-03-02 | Glaxo Group Ltd | Chemical compound |
US4957921A (en) | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
US5047406A (en) | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
JPH04275280A (ja) | 1991-03-04 | 1992-09-30 | Nippon Chem Ind Co Ltd | 4h−2,3−ジヒドロ−2−イミノ−1,3−ベンゾチアジン−4−オン類の製造方法 |
JPH0532586A (ja) | 1991-07-26 | 1993-02-09 | Mitsubishi Petrochem Co Ltd | 2,6−ナフタレンジカルボン酸の製造方法 |
DE4141268A1 (de) * | 1991-12-14 | 1993-06-17 | Merck Patent Gmbh | Pharmazeutische zubereitung |
JPH05310745A (ja) | 1992-05-13 | 1993-11-22 | Takeda Chem Ind Ltd | ジエラジラクトンおよび抗炎症剤 |
ATE372966T1 (de) | 1994-03-25 | 2007-09-15 | Isotechnika Inc | Verbesserung der effektivität von arzneimitteln duren deuterierung |
US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
US20010009912A1 (en) | 1995-02-10 | 2001-07-26 | Christos Tsaklakidis | New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds |
IL122974A (en) * | 1995-08-18 | 2000-11-21 | Purdue Research Foundation | Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them |
US5977110A (en) | 1995-09-22 | 1999-11-02 | Warner-Lambert Company | Substituted cyclohexylamines as central nervous systems agents |
US5807575A (en) * | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
US5910319A (en) | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
KR100672186B1 (ko) | 1998-03-31 | 2007-01-19 | 아카디아 파마슈티칼스 인코포레이티드 | 무스카린 수용체에 대해 활성을 갖는 화합물 |
SE9802208D0 (sv) | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
PL345166A1 (en) | 1998-06-30 | 2001-12-03 | Zeria Pharm Co Ltd | N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof |
EP1611881A1 (en) * | 1999-03-31 | 2006-01-04 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
US6489341B1 (en) | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
US20070009931A1 (en) * | 2000-08-04 | 2007-01-11 | Kirsch Wolff M | Negative correlation between IRP-2 and Transferrin receptor expression as a diagnostic of Alzheimer's disease |
US7122576B2 (en) | 2001-02-27 | 2006-10-17 | Plata-Salaman Carlos R | Carbamate compounds for use in preventing or treating bipolar disorder |
WO2002100350A2 (en) * | 2001-06-13 | 2002-12-19 | The Regents Of University Of Michigan | Dopamine receptor ligands and therapeutic methods based thereon |
US6566550B2 (en) | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
SE0200301D0 (sv) | 2002-02-01 | 2002-02-01 | Axon Biochemicals Bv | Thio-carbostyril derivative |
US6919342B2 (en) | 2003-06-05 | 2005-07-19 | Abbott Gmbh & Co. Kg | Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
HU227534B1 (en) | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
CN101005829A (zh) * | 2003-10-21 | 2007-07-25 | 艾克塔维斯集团公司 | 喹硫平制剂 |
KR100641825B1 (ko) | 2003-11-05 | 2006-11-02 | 주식회사 코오롱 | 4-바이페닐아세트산의 제조 방법 |
US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
DE102004047517A1 (de) | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
UY29161A1 (es) | 2004-10-15 | 2006-04-28 | Bayer Pharmaceuticals Corp | Nuevos heterociclos |
HUP0500170A3 (en) | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
US8846100B2 (en) * | 2006-05-12 | 2014-09-30 | Shire Llc | Controlled dose drug delivery system |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
KR20150023937A (ko) | 2007-05-11 | 2015-03-05 | 리히터 게데온 닐트. | 카르바모일-사이클로헥산 유도체의 신규한 용매화물 및 결정 형태 |
HU230748B1 (hu) | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
HUP0700353A2 (en) | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
HUP0700369A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia |
HUP0700370A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania |
MX2010001171A (es) | 2007-08-01 | 2010-03-01 | Lundbeck & Co As H | Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sistema dopaminergico. |
MY157192A (en) | 2007-08-03 | 2016-05-13 | Richter Gedeon Nyrt | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands |
US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
EP2251011B1 (en) * | 2008-02-21 | 2012-04-04 | Richter Gedeon Nyrt. | Solid preparation for oral administration |
PL2317852T3 (pl) | 2008-07-16 | 2015-05-29 | Richter Gedeon Nyrt | Preparaty farmaceutyczne zawierające ligandy receptora dopaminy |
HU229858B1 (en) | 2008-12-17 | 2014-10-28 | Richter Gedeon Nyrt | Process for the preparation of trans 4-amino-cyclohexyl acetic acid ethyl ester hcl |
HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
WO2010126527A1 (en) | 2009-05-01 | 2010-11-04 | Forest Laboratories Holdings Limited | Methods of treating cns disorders |
WO2011060363A2 (en) | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
JP2015521175A (ja) | 2012-05-07 | 2015-07-27 | エコ・ファーマシューティカルズ・ビー.ブイ.Echo Pharmaceuticals B.V. | カンナビノイド含有粒状体、その製造方法、及びこのような粒状体を含む経口投与単位 |
WO2014031162A1 (en) | 2012-08-20 | 2014-02-27 | Forest Laboratories Holdings Limited | Crystalline form of carbamoyl-cyclohexane derivatives |
HU231227B1 (hu) | 2012-11-29 | 2022-03-28 | Richter Gedeon Nyrt. | Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére |
ITMI20131693A1 (it) | 2013-10-14 | 2015-04-15 | Chemo Res S L | Derivati della 1,4-cicloesilammina e loro preparazione |
RS56931B1 (sr) | 2013-12-13 | 2018-05-31 | Pf Medicament | Hromonski derivat kao antagonist dopaminskog d3 receptora za upotrebu u lečenju poremećaja autističnog spektra |
CN105218484B (zh) | 2015-09-14 | 2018-02-23 | 安徽省逸欣铭医药科技有限公司 | 酒石酸卡利拉嗪及其制备方法和医药用途 |
CN105330616B (zh) | 2015-12-09 | 2017-09-26 | 苏州明锐医药科技有限公司 | 卡利拉嗪的制备方法 |
EP3231418A1 (en) | 2016-04-14 | 2017-10-18 | Richter Gedeon Nyrt. | Granule formulation for oral administration |
US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
HUP1700253A1 (hu) | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
-
2009
- 2009-07-16 PL PL09798745T patent/PL2317852T3/pl unknown
- 2009-07-16 CN CN2009801307461A patent/CN102118970A/zh active Pending
- 2009-07-16 US US12/504,149 patent/US9056845B2/en not_active Ceased
- 2009-07-16 SI SI200931157T patent/SI2317852T1/sl unknown
- 2009-07-16 CA CA2730287A patent/CA2730287C/en not_active Expired - Fee Related
- 2009-07-16 AP AP2011005549A patent/AP2975A/xx active
- 2009-07-16 CN CN201510433904.8A patent/CN104997743A/zh active Pending
- 2009-07-16 PT PT09798745T patent/PT2317852E/pt unknown
- 2009-07-16 RS RS20150186A patent/RS53866B1/en unknown
- 2009-07-16 EP EP09798745.7A patent/EP2317852B1/en active Active
- 2009-07-16 SG SG2013053608A patent/SG192507A1/en unknown
- 2009-07-16 UA UAA201101837A patent/UA104869C2/uk unknown
- 2009-07-16 AU AU2009270823A patent/AU2009270823B2/en active Active
- 2009-07-16 WO PCT/US2009/050835 patent/WO2010009309A1/en active Application Filing
- 2009-07-16 DK DK09798745T patent/DK2317852T3/en active
- 2009-07-16 BR BRPI0916241A patent/BRPI0916241A2/pt not_active Application Discontinuation
- 2009-07-16 MY MYPI2011000197A patent/MY156288A/en unknown
- 2009-07-16 KR KR1020117003248A patent/KR101612146B1/ko active IP Right Grant
- 2009-07-16 EA EA201170198A patent/EA025636B1/ru unknown
- 2009-07-16 MX MX2011000622A patent/MX2011000622A/es active IP Right Grant
- 2009-07-16 JP JP2011518910A patent/JP5774988B2/ja active Active
- 2009-07-16 ES ES09798745.7T patent/ES2532636T3/es active Active
- 2009-07-16 NZ NZ590852A patent/NZ590852A/xx unknown
- 2009-07-16 GE GEAP200912106A patent/GEP20146052B/en unknown
-
2011
- 2011-01-13 NI NI201100016A patent/NI201100016A/es unknown
- 2011-01-13 IL IL210615A patent/IL210615A/en active IP Right Grant
- 2011-01-14 CL CL2011000091A patent/CL2011000091A1/es unknown
- 2011-02-04 CO CO11013243A patent/CO6351689A2/es not_active Application Discontinuation
- 2011-02-11 ZA ZA2011/01134A patent/ZA201101134B/en unknown
- 2011-02-15 MA MA33622A patent/MA32568B1/fr unknown
- 2011-02-16 EC EC2011010834A patent/ECSP11010834A/es unknown
-
2012
- 2012-10-17 US US13/653,576 patent/US9056846B2/en not_active Ceased
-
2015
- 2015-02-13 CY CY20151100149T patent/CY1115994T1/el unknown
- 2015-02-19 HR HRP20150196TT patent/HRP20150196T1/hr unknown
- 2015-03-13 SM SM201500063T patent/SMT201500063B/xx unknown
-
2017
- 2017-05-18 US US15/598,971 patent/USRE47350E1/en active Active
- 2017-05-18 US US15/598,784 patent/USRE47333E1/en active Active
-
2019
- 2019-04-01 US US16/372,031 patent/USRE49110E1/en active Active
- 2019-04-15 US US16/384,264 patent/USRE49302E1/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2975A (en) | Pharmaceutical formulations containing dopamine receptor ligands | |
ZA201104336B (en) | Pharmaceutical compounds | |
HK1164059A1 (en) | Compositions for drug administration | |
GB0816372D0 (en) | Pharmaceutical compounds | |
ZA201004793B (en) | Capsule formulation | |
GB0820819D0 (en) | Pharmaceutical compounds | |
GB0801416D0 (en) | Pharmaceutical compounds | |
EP2281557A4 (en) | PHARMACEUTICAL FORMULATION CONTAINING AN ANGIOTENSIN II RECEPTOR BLOCKING AGENT | |
EP2205218A4 (en) | ESOMEPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION | |
GB0816371D0 (en) | Pharmaceutical compounds | |
GB0812969D0 (en) | Pharmaceutical compounds | |
PL2271618T3 (pl) | Farmaceutyczne związki | |
GB0816370D0 (en) | Pharmaceutical compounds | |
PL394605A1 (pl) | Trwała złożona kompozycja farmaceutyczna | |
EP2268278A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP2306998A4 (en) | PHARMACEUTICAL FORMULATION | |
GB0810857D0 (en) | Pharmaceutical compounds | |
ZA201007197B (en) | Raloxifene pharmaceutical formulations | |
GB0818725D0 (en) | Pharmaceutical composition | |
GB0817969D0 (en) | Pharmaceutical composition | |
HK1182939A1 (en) | Stable pharmaceutical composition | |
ZA201001127B (en) | Pharmaceutical formulation for extended release | |
GB0810217D0 (en) | Pharmaceutical formulations | |
GB0813031D0 (en) | Pharmaceutical formulations | |
GB0820825D0 (en) | Pharmaceutical compounds |